Page 334 - Read Online

Page 20 of 23 Monks et al. J Cancer Metastasis Treat 2019;5:24 I http://dx.doi.org/10.20517/2394-4722.2018.79

2009;82:203-8.
97. Goktas S, Yilmaz MI, Caglar K, Sonmez A, Kilic S, et al. Prostate cancer and adiponectin. Urology 2005;65:1168-72.
98. Baillargeon J, Platz EA, Rose DP, Pollock BH, Ankerst DP, et al. Obesity, adipokines, and prostate cancer in a prospective population-based
study. Cancer Epidemiol Biomarkers Prev 2006;15:1331-5.
99. Kerenidi T, Lada M, Tsaroucha A, Georgoulias P, Mystridou P, et al. Clinical significance of serum adipokines levels in lung cancer. Med
Oncol 2013;30:507.
100. Karapanagiotou EM, Tsochatzis EA, Dilana KD, Tourkantonis I, Gratsias I, et al. The significance of leptin, adiponectin, and resistin serum
levels in non-small cell lung cancer (NSCLC). Lung Cancer 2008;61:391-7.
101. Petridou ET, Sergentanis TN, Antonopoulos CN, Dessypris N, Matsoukis IL, et al. Insulin resistance: an independent risk factor for lung
cancer? Metabolism 2011;60:1100-6.
102. Iwabu M, Yamauchi T, Okada-Iwabu M, Sato K, Nakagawa T, et al. Adiponectin and AdipoR1 regulate PGC-1α and mitochondria by Ca2+
and AMPK/SIRT1. Nature 2010;464:1313-9.
103. Yamauchi T, Kamon J, Minokoshi Y, Ito Y, Waki H, et al. Adiponectin stimulates glucose utilization and fatty-acid oxidation by activating
AMP-activated protein kinase. Nat Med 2002;8:1288-95.
104. Li W, Saud SM, Young MR, Chen G, Hua B. Targeting AMPK for cancer prevention and treatment. Oncotarget 2015;6:7365-78.
105. Engelman JA, Chen L, Tan X, Crosby K, Guimaraes AR, et al. Effective use of PI3K and MEK inhibitors to treat mutant Kras G12D and
PIK3CA H1047R murine lung cancers. Nat Med 2008;14:1351-6.
106. Majumder PK, Febbo PG, Bikoff R, Berger R, Xue Q, et al. mTOR inhibition reverses Akt-dependent prostate intraepithelial neoplasia
through regulation of apoptotic and HIF-1-dependent pathways. Nat Med 2004;10:594-601.
107. Paquette M, El-Houjeiri L, Pause A. mTOR Pathways in Cancer and Autophagy. Cancers (Basel) 2018;10:18.
108. Meisse D, Van de Casteele M, Beauloye C, Hainault I, Kefas BA, et al. Sustained activation of AMP-activated protein kinase induces c-Jun
N-terminal kinase activation and apoptosis in liver cells. FEBS Lett 2002;526:38-42.
109. Kuhajda FP. AMP-activated protein kinase and human cancer: cancer metabolism revisited. Int J Obes 2008;32:S36-41.
110. Yano S, Tokumitsu H, Soderling TR. Calcium promotes cell survival through CaM-K kinase activation of the protein-kinase-B pathway.
Nature 1998;396:584-7.
111. Habeeb BS, Kitayama J, Nagawa H. Adiponectin supports cell survival in glucose deprivation through enhancement of autophagic response
in colorectal cancer cells. Cancer Sci 2011;102:999-1006.
112. Lam JB, Chow KH, Xu A, Lam KS, Liu J, et al. Adiponectin haploinsufficiency promotes mammary tumor development in MMTV-PyVT
mice by modulation of phosphatase and tensin homolog activities. PLoS One 2009;4:e4968.
113. Karim R, Tse G, Putti T, Scolyer R, Lee S. The significance of the Wnt pathway in the pathology of human cancers. Pathology 2004;36:120-8.
114. Yu H, Pardoll D, Jove R. STATs in cancer inflammation and immunity: a leading role for STAT3. Nat Rev Cancer 2009;9:798-809.
115. Miyazaki T, Bub JD, Uzuki M, Iwamoto Y. Adiponectin activates c-Jun NH2-terminal kinase and inhibits signal transducer and activator of
transcription 3. Biochem Biophys Res Commun 2005;333:79-87.
116. Saxena NK, Fu PP, Nagalingam A, Wang J, Handy J, et al. Adiponectin modulates C-jun N-terminal kinase and mammalian target of
rapamycin and inhibits hepatocellular carcinoma. Gastroenterology 2010;139:1762-73, 1773.e1-5.
117. Tan PH, Tyrrell HEJ, Gao L, Xu D, Quan J, et al. Adiponectin receptor signaling on dendritic cells blunts antitumor immunity. Cancer Res
2014;74:5711-22.
118. Chen MJ, Yeh YT, Lee KT, Tsai CJ, Lee HH, et al. The promoting effect of adiponectin in hepatocellular carcinoma. J Surg Oncol
2012;106:181-7.
119. Chung SJ, Nagaraju GP, Nagalingam A, Muniraj N, Kuppusamy P, et al. ADIPOQ/adiponectin induces cytotoxic autophagy in breast cancer
cells through STK11/LKB1-mediated activation of the AMPK-ULK1 axis. Autophagy 2017;13:1386-403.
120. Guo W, Wang Y, Wang Z, Wang YP, Zheng H. Inhibiting autophagy increases epirubicin’s cytotoxicity in breast cancer cells. Cancer Sci
2016;107:1610-21.
121. Xia JY, Holland WL, Kusminski CM, Sun K, Sharma AX, et al. Targeted induction of ceramide degradation leads to improved systemic
metabolism and reduced hepatic steatosis. Cell Metab 2015;22:266-78.
122. Aerts JM, Ottenhoff R, Powlson AS, Grefhorst A, Eijk M van, et al. Pharmacological inhibition of glucosylceramide synthase enhances
insulin sensitivity. Diabetes 2007;56:1341-9.
123. Holland WL, Miller RA, Wang ZV, Sun K, Barth BM, et al. Receptor-mediated activation of ceramidase activity initiates the pleiotropic
actions of adiponectin. Nat Med 2011;17:55-63.
124. Obata Y, Kita S, Koyama Y, Fukuda S, Takeda H, et al. Adiponectin/T-cadherin system enhances exosome biogenesis and decreases cellular
ceramides by exosomal release. JCI Insight 2018;3:99680.
125. Andreeva AV, Kutuzov MA. Cadherin 13 in cancer. Genes Chromosomes Cancer 2010;49:775-90.
126. Lengyel E, Makowski L, DiGiovanni J, Kolonin MG. Cancer as a matter of fat: the crosstalk between adipose tissue and tumors. Trends
Cancer 2018;4:374-84.
127. Wolf AM, Wolf D, Rumpold H, Enrich B, Tilg H. Adiponectin induces the anti-inflammatory cytokines IL-10 and IL-1RA in human
leukocytes. Biochem Biophys Res Commun 2004;323:630-5.
128. Qi GM, Jia LX, Li YL, Li HH, Du J. Adiponectin suppresses angiotensin II-induced inflammation and cardiac fibrosis through activation of
macrophage autophagy. Endocrinology 2014;155:2254-65.
129. Park P, Huang H, McMullen MR, Bryan K, Nagy LE. Activation of cyclic-AMP response element binding protein contributes to
adiponectin-stimulated interleukin-10 expression in raw 264.7 macrophages. J Leukoc Biol 2008;83:1258-66.
130. Mandal P, Pratt BT, Barnes M, McMullen MR, Nagy LE. Molecular mechanism for adiponectin-dependent M2 macrophage polarization:
link between the metabolic and innate immune activity of full-length adiponectin. J Biol Chem 2011;286:13460-9.
131. Wulster-Radcliffe MC, Ajuwon KM, Wang J, Christian JA, Spurlock ME. Adiponectin differentially regulates cytokines in porcine